Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-03-07FDA Approved: METHOTREXATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for METHOTREXATE SODIUM from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis [Phase 2]
Pfizer conducted a Phase 2 trial to evaluate the safety and efficacy of a novel topical ointment for plaque psoriasis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis [Phase 2]
Pfizer completed a Phase 2 safety and efficacy study of a novel ointment for plaque psoriasis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome [Phase 4]
Phase 4 study assessing whether genetic screening for HLA-B*1301 can predict susceptibility to dapsone hypersensitivity syndrome.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis [NA]
Completed clinical trial evaluating localized narrowband UV-B phototherapy (Levia) for plaque psoriasis; results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-02-16FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for clobetasol propionate topical corticosteroid from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet [Phase 4]
A completed Phase 4 clinical trial evaluating the safety and efficacy of efalizumab (Raptiva) in adult patients with plaque psoriasis involv…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects [Phase 1]
This Phase 1 first-in-human study of an anti-IL-20 therapy for psoriasis evaluated safety and tolerability with early biological and clinica…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis [Phase 2]
This document reports the completion of a Phase 2 trial evaluating topical Indigo Naturalis for mild to moderate plaque-type psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects [Phase 1]
A Phase 1 multiple ascending dose trial of MSB0010841, an anti-IL17A/F nanobody, in psoriasis subjects has completed and results were posted…
-
FDA approval · 2017-01-12FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' original ANDA for Triamcinolone Acetonide topical (generic), clearing a new generic product on the mar…
-
FDA approval · 2017-01-11FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone topical generic under an Original Application (ANDA 208163).
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis
This clinical trial update describes a study comparing cathelicidin expression in skin and saliva of patients with atopic dermatitis and pso…
-
FDA approval · 2017-01-09FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone as a generic topical corticosteroid under an original ANDA.
-
FDA approval · 2017-01-06FDA Approved: DESOXIMETASONE — Original Application (Saptalis Pharmaceuticals, LLC.)
The FDA approved an original ANDA application from Saptalis Pharmaceuticals for a desoximetasone topical product, a generic corticosteroid f…
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, and efficacy of AMG 827 in psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris [Phase 3]
A Phase 3 clinical trial evaluating LEO 90100 Aerosol Foam and Daivobet Gel in psoriasis vulgaris has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis [Phase 1]
This document reports the completion of a Phase 1 safety study of BMS-986165 in healthy subjects and in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab. [NA]
The trial evaluated cardiovascular effects of adalimumab in psoriasis patients; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 [Phase 1]
A Phase 1 trial in psoriasis examined how LAS41008 interacts with Monomethyl Fumarate (MMF); the study has completed.
-
CLINICAL_TRIALS research · 2016-12-22Clinical Trial Update: Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
A clinical trial update comparing psychological impact in patients with hidradenitis suppurativa versus psoriasis.
-
FDA approval · 2016-12-20FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
FDA approved a supplemental application for TREXALL (methotrexate) from Teva Women's Health, Inc.
-
FDA approval · 2016-12-12FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic desoximetasone topical (original application) for relief of inflammatory and pruritic manifestat…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
This completed observational study examines whether trough serum levels of etanercept and antibodies against etanercept correlate with its e…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis [Phase 3]
A Phase 3 trial evaluating efalizumab for moderate to severe psoriasis has completed.